Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

Nov 16, 2010

30071_dirs_2010-11-16_9945a48d-cf73-4a28-8f89-782875670b0e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-12

Reporting Person: Jacobsen Stein (COO, Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-12 ResMed Common Stock M 24000 $23.095 Acquired 64222.656 Direct
2010-11-12 ResMed Common Stock S 24000 $33.2538 Disposed 40222.656 Direct
2010-11-12 ResMed Common Stock M 37500 $21.71 Acquired 77722.656 Direct
2010-11-12 ResMed Common Stock S 37500 $33.214 Disposed 40222.656 Direct
2010-11-12 ResMed Common Stock M 6000 $21.025 Acquired 46222.656 Direct
2010-11-12 ResMed Common Stock S 6000 $33.25 Disposed 40222.656 Direct
2010-11-12 ResMed Common Stock M 10000 $21.675 Acquired 50222.656 Direct
2010-11-12 ResMed Common Stock S 10000 $33.25 Disposed 40222.656 Direct
2010-11-12 ResMed Common Stock S 10222 $33.241 Disposed 30000.656 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-11-12 ResMed Common Stock Options $23.095 M 24000 Disposed 2013-11-10 ResMed Common Stock (24000) Direct
2010-11-12 ResMed Common Stock Options $21.71 M 37500 Disposed 2014-08-01 ResMed Common Stock (37500) Direct
2010-11-12 ResMed Common Stock Options $21.025 M 6000 Disposed 2014-11-07 ResMed Common Stock (6000) Direct
2010-11-12 ResMed Common Stock Options $21.675 M 10000 Disposed 2015-10-01 ResMed Common Stock (10000) Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 12/17/2009 and vesting 11/11/2010.

F2: This transaction was executed in multiple trades at prices ranging from $33.24 to 33.285. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: This transaction was executed in multiple trades at prices ranging from $33.19 to 33.258. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: This transaction was executed in multiple trades at prices ranging from $33.24 to 33.25. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.